Evidence map›Paper›PMID 37353342›Full record

Observational studyStroke and vascular neurology2024

Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study.

Simon Hellwig, Thomas Krause, Jan F Scheitz, Juliane Herm, Ulrike Grittner, Nadja Jauert, Jochen B Fiebach, Mario Kasner, Wolfram Doehner, Matthias Endres and 4 more

Registry-linked trialOpen access · goldAbstract readObservational StudyComparative Study
In one paragraph

Observational study in Stroke and vascular neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02142413 (HEart and BRain Interfaces in Acute Ischemic Stroke), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02142413 completednot on this map

HEart and BRain Interfaces in Acute Ischemic Stroke (HEBRAS) - A Prospective Oberservational Cohort Study

TypeobservationalSponsorCharite University, Berlin, GermanyRan2014 to 2018Enrolled368ConditionsStroke, Atrial Fibrillation
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Simon HellwigDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-6925-4768
Thomas KrauseDepartment of Neurology, Jüdisches Krankenhaus Berlin, Berlin, Germany.
Jan F ScheitzDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5835-4627
Juliane HermDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-6873-2812
Ulrike GrittnerInstitute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-2595-0224
Nadja JauertCenter for Stroke Research Berlin, Berlin, Germany.
Jochen B FiebachCenter for Stroke Research Berlin, Berlin, Germany.ORCID 0000-0002-7936-6958
Mario KasnerDepartment of Cardiology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Wolfram DoehnerCenter for Stroke Research Berlin, Berlin, Germany.ORCID 0000-0001-7598-708X
Matthias EndresDepartment of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-6520-3720
Rolf WachterDepartment of Cardiology, University Hospital Leipzig, Leipzig, Germany.ORCID 0000-0003-2231-2200
Thomas ElgetiDepartment of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-7155-6044
Christian H Nolte *Department of Neurology with Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5577-1775
Karl Georg Haeusler *Department of Neurology, University Hospital Würzburg, Würzburg, Germany haeusler_k@ukw.de.ORCID 0000-0002-6389-5054
Humboldt-Universität zu Berlin · DECharité - Universitätsmedizin Berlin · DEGerman Center for Neurodegenerative Diseases · DEGerman Centre for Cardiovascular Research · DEJüdisches Krankenhaus Berlin · DEUniversitätsklinikum Würzburg · DEUniversity Hospital Leipzig · DEZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStroke aetiology remains cryptogenic in a relevant proportion of patients with acute ischaemic stroke (AIS). We assessed whether enhanced diagnostic workup after AIS yields a higher rate of prespecified pathological findings compared with routine diagnostic care in-hospital.

methodsHospitalised patients with AIS were prospectively enrolled in the investigator-initiated observational HEart and BRain Interfaces in Acute Ischaemic Stroke (HEBRAS) study at the Charité, Berlin, Germany. Patients with AIS without known atrial fibrillation (AF) underwent cardiovascular MR imaging (CMR), MR-angiography of the aortic arch and prolonged Holter-ECG monitoring on top of routine diagnostic care.

resultsAmong 356 patients with AIS (mean age 66 years, 37.6% female), enhanced workup yielded a higher rate of prespecified pathological findings compared with routine care (17.7% vs 5.3%; p<0.001). Consequently, fewer patients were classified as cryptogenic after enhanced diagnostic workup (38.5% vs 45.5%, p<0.001). Routine care included echocardiography in 228 (64.0%) patients. CMR was successfully performed in 292 (82.0%) patients and revealed more often a prespecified pathological finding compared with routine echocardiography (16.1% vs 5.3%). Furthermore, study-related ECG monitoring (median duration 162 hours (IQR 98-210)) detected AF in 16 (4.5%) patients, while routine monitoring (median duration 51 hours (IQR 34-74)) detected AF in seven (2.0%) patients.

conclusionsEnhanced diagnostic workup revealed a higher rate of prespecified pathological findings in patients with AIS compared with routine diagnostic care and significantly reduced the proportion of patients with cryptogenic stroke. TRIAL REGISTRATION NUMBER: NCT02142413.

Indexed as

Electrocardiography, AmbulatoryIschemic StrokePredictive Value of TestsAgedAged, 80 and overAorta, ThoracicBerlinEchocardiographyFemaleHumansMagnetic Resonance AngiographyMagnetic Resonance ImagingMaleMiddle AgedPrognosisProspective StudiesAtrial FibrillationClinical TrialMagnetic Resonance ImagingStroke

Identifiers

PMID37353342
PMCPMC11103153
OpenAlexW4381733090

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.